Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT
出版年份 2020 全文链接
标题
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT
作者
关键词
-
出版物
HEALTH TECHNOLOGY ASSESSMENT
Volume 24, Issue 47, Pages 1-86
出版商
National Institute for Health Research
发表日期
2020-09-25
DOI
10.3310/hta24470
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
- (2018) Brendan Mulhern et al. PHARMACOECONOMICS
- 3L, 5L, What the L? A NICE Conundrum
- (2018) Nancy Devlin et al. PHARMACOECONOMICS
- Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
- (2018) Baptiste Leurent et al. PHARMACOECONOMICS
- EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom
- (2018) Monica Hernandez Alava et al. VALUE IN HEALTH
- Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)
- (2018) Macey L. Murray et al. BMC Medical Research Methodology
- Valuing health-related quality of life: An EQ-5D-5L value set for England
- (2017) Nancy J. Devlin et al. HEALTH ECONOMICS
- British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015
- (2016) Anna Maria Geretti et al. HIV MEDICINE
- Self-administered interventions for anogenital warts in immunocompetent patients: a systematic review and meta-analysis
- (2016) Ricardo Niklas Werner et al. SEXUALLY TRANSMITTED INFECTIONS
- Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report
- (2015) Scott D. Ramsey et al. VALUE IN HEALTH
- Immunomodulatory effects of EGCG fraction of green tea extract in innate and adaptive immunity via T regulatory cells in murine model
- (2014) Chao-Lin Kuo et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Efficacy of the HPV-16/18 vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial
- (2014) Allan Hildesheim et al. VACCINE
- Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM
- (2013) Thomas C.S. Martin et al. AIDS
- Factors associated with the immune response to hepatitis A vaccination in HIV-infected patients in the era of highly active antiretroviral therapy
- (2013) Guillermo Mena et al. VACCINE
- A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18
- (2012) Stephen E Goldstone et al. Expert Review of Vaccines
- 2012 European guideline for the management of anogenital warts
- (2012) C.J.N. Lacey et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets
- (2012) Ben van Hout et al. VALUE IN HEALTH
- Analyses of human papillomavirus genotypes and viral loads in anogenital warts
- (2011) Siolian L.R. Ball et al. JOURNAL OF MEDICAL VIROLOGY
- Condyloma accuminatum treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, 18)
- (2011) Hee Jung Lee et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
- (2011) M. Herdman et al. QUALITY OF LIFE RESEARCH
- Genital warts and cost of care in England
- (2011) S. Desai et al. SEXUALLY TRANSMITTED INFECTIONS
- The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK
- (2011) S. C. Woodhall et al. SEXUALLY TRANSMITTED INFECTIONS
- Recalcitrant Cutaneous Warts Treated With Recombinant Quadrivalent Human Papillomavirus Vaccine (Types 6, 11, 16, and 18) in a Developmentally Delayed, 31-Year-Old White Man
- (2010) Supriya S. Venugopal ARCHIVES OF DERMATOLOGY
- Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
- (2010) Sven-Eric Olsson et al. Human vaccines & immunotherapeutics
- Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta-analysis
- (2010) TG Tzellos et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Sinecatechins, a Defined Green Tea Extract, in the Treatment of External Anogenital Warts
- (2010) Silvio Tatti et al. OBSTETRICS AND GYNECOLOGY
- Efficacy and Safety of Imiquimod Versus Podophyllotoxin in the Treatment of Anogenital Warts
- (2010) Peter Komericki et al. SEXUALLY TRANSMITTED DISEASES
- Multiple imputation using chained equations: Issues and guidance for practice
- (2010) Ian R. White et al. STATISTICS IN MEDICINE
- Topical Polyphenon®E in the treatment of external genital and perianal warts: a randomized controlled trial
- (2008) E. Stockfleth et al. BRITISH JOURNAL OF DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More